Pembrolizumab belongs to a class of medications known as immunotherapy. It works with your body's immune system to fight against the tumour cells.
Other possible side effects (usually mild, may occur within a few weeks after 1st dose)
Please seek medical attention if any of the following occurs:
Subcribe to our mailing list to get the updates to your email inbox...
Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.